Compounds > glutamine

glutamine and ritonavir

glutamine has been researched along with ritonavir in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Adekola, KU; Bajpai, R; Dalva-Aydemir, S; Kandela, I; Koblinski, JE; Martinez, M; Raje, NS; Rosen, ST; Shanmugam, M; Singhal, S; Wei, C1
Bajpai, R; Boise, LH; Lonial, S; Matulis, SM; Nooka, AK; Shanmugam, M; Von Hollen, HE; Wei, C1

Reviews

1 review(s) available for glutamine and ritonavir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for glutamine and ritonavir

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Mar-01, Volume: 21, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Electron Transport Complex I; Gene Expression; Glucose Transporter Type 4; Glutamine; Humans; Mechanistic Target of Rapamycin Complex 1; Metformin; Mice; Mitochondria; Multiple Myeloma; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Invasiveness; Oxygen Consumption; Proto-Oncogene Proteins c-akt; Ritonavir; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2015
Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax.
    Oncogene, 2016, 07-28, Volume: 35, Issue:30

    Topics: Antineoplastic Agents; Bcl-2-Like Protein 11; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Glucose Transporter Type 4; Glutamine; Humans; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Ritonavir; Sulfonamides

2016